Lecanameb, the newly FDA approved drug, is likely to cost about $27,000 a year, according to various websites. While some with Mild Cognitive Impairment can afford the drug, most cannot. This inequity...
DATE: Jan 13, 2023
CATEGORY: Letters to the Editor